Home

Galectin Therapeutics Inc. - Common Stock (GALT)

3.1982
+0.8082 (33.82%)
NASDAQ · Last Trade: Jun 18th, 4:11 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
Issued on behalf of Oncolytics Biotech Inc.   Vancouver, BC – June 18, 2025 – USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer. In fact, the report cites a recent study from the National Institutes of Health (NIH), which found that between […]
Via FinancialNewsMedia · June 18, 2025